Spectral-domain optical coherence tomography (SD-OCT) patterns and response to intravitreal bevacizumab therapy in macular edema associated with branch retinal vein occlusion

被引:61
作者
Kang, Hae Min [1 ]
Chung, Eun Jee [2 ]
Kim, Yong Min [3 ]
Koh, Hyoung Jun [1 ,4 ]
机构
[1] Yonsei Univ, Coll Med, Dept Ophthalmol, Inst Vis Res, Seoul 120752, South Korea
[2] Ilsan Hosp, Natl Hlth Insurance Corp, Dept Ophthalmol, Goyang, South Korea
[3] Siloam Eye Hosp, Seoul, South Korea
[4] Yonsei Univ, Coll Med, Dept Ophthalmol, Seoul 120752, South Korea
关键词
Branch retinal vein occlusion; Bevacizumab; Macular edema; Intravitreal injection; Spectral-domain optical coherence tomography; FOVEAL PHOTORECEPTOR LAYER; CENTRAL SEROUS CHORIORETINOPATHY; VISUAL-ACUITY; SECONDARY; AVASTIN;
D O I
10.1007/s00417-012-2067-8
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
To evaluate the baseline spectral-domain optical coherence tomography (SD-OCT) characteristics of macular edema (ME) due to branch retinal vein occlusion (BRVO) for visual outcome after intravitreal bevacizumab injection. Fifty-nine patients treated in one eye with intravitreal bevacizumab for ME due to BRVO were retrospectively reviewed. Stepwise multiple regression analysis was used to evaluate the relative contribution of several variables, including SD-OCT characteristics such as photoreceptor inner segment/outer segment (IS/OS) integrity and external limiting membrane (ELM status), baseline best-corrected visual acuity (BCVA), and baseline central retinal thickness (CRT) with final visual outcome. Thirty-one patients (52.5 %) had disrupted photoreceptor IS/OS integrity. The mean BCVA improved significantly from 0.50 logMAR (20/63 Snellen equivalent) to 0.10 logMAR (20/25 Snellen equivalent) in the intact photoreceptor group (p = 0.000, paired t-test). However, the mean BCVA was improved in the disrupted photoreceptor group, from 1.10 logMAR (20/252 Snellen equivalent) to 0.94 logMAR (20/174 Snellen equivalent), which was not statistically significant (p = 0.177, paired t-test). ELM was disrupted in 23 patients (39.0 %). The mean BCVA improved significantly from 0.63 logMAR (20/85 Snellen equivalent) to 0.26 logMAR (20/36 Snellen equivalent) in the intact ELM group (p = 0.000, paired t-test), however, not significantly improved in the disrupted ELM group, from 1.09 logMAR (20/246 Snellen equivalent) to 1.01 logMAR (20/205 Snellen equivalent) (p = 0.563, paired t-test). The strongest individual predictor of final BCVA among patients with ME due to BRVO was the integrity of photoreceptor IS/OS layer on SD OCT (r (2) = 0.514, p = 0.000, stepwise multiple regression), but the most efficient model was the combination of the photoreceptor IS/OS integrity, ELM status, and baseline BCVA (r (2) = 0.671, p = 0.000, stepwise multiple regression). The strongest predictor of final BCVA was the status of photoreceptor IS/OS integrity (beta = 0.532, p = 0.000, stepwise multiple regression), followed by ELM status (beta = 0.325, p = 0.006, stepwise multiple regression), and the baseline BCVA (beta = 0.238, p = 0.013, stepwise multiple regression). Our results suggest that baseline SD-OCT characteristics, the status of photoreceptor IS/OS and ELM can be helpful in predicting the final visual outcome after intravitreal bevacizumab injection in these patients.
引用
收藏
页码:501 / 508
页数:8
相关论文
共 30 条
[1]   Predictive factors for changes in macular edema in intravitreal bevacizumab therapy of retinal vein occlusion [J].
Ach, Thomas ;
Hoeh, Alexandra E. ;
Schaal, Karen B. ;
Scheuerle, Alexander F. ;
Dithmar, Stefan .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 248 (02) :155-159
[2]  
[Anonymous], 1984, AM J OPHTHALMOL, V98, P271
[3]   Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema [J].
Avitabile, T ;
Longo, A ;
Reibaldi, A .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2005, 140 (04) :695-702
[4]   The treatment of branch retinal vein occlusion with bevacizumab [J].
Badala, Federico .
CURRENT OPINION IN OPHTHALMOLOGY, 2008, 19 (03) :234-238
[5]   Optical Coherence Tomographic Hyperreflective Foci A Morphologic Sign of Lipid Extravasation in Diabetic Macular Edema [J].
Bolz, Matthias ;
Schmidt-Erfurth, Ursula ;
Deak, Gabor ;
Mylonas, Georgios ;
Kriechbaum, Katharina ;
Scholda, Christoph .
OPHTHALMOLOGY, 2009, 116 (05) :914-920
[6]   Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion [J].
Chung, Eun Jee ;
Hong, Young Taek ;
Lee, Sung Chul ;
Kwon, Oh Woong ;
Koh, Hyoung Jun .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2008, 246 (09) :1241-1247
[7]   Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions - IBeVO study [J].
Costa, Rogerio A. ;
Jorge, Rodrigo ;
Calucci, Daniela ;
Melo, Luiz A., Jr. ;
Cardillo, Jose A. ;
Scott, Ingrid U. .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (02) :141-149
[8]   Optical coherence tomography in unilateral resolved central serous chorioretinopathy [J].
Eandi, CM ;
Chung, JE ;
Cardillo-Piccolino, F ;
Spaide, RF .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2005, 25 (04) :417-421
[9]   MACULAR EDEMA AND RETINAL BRANCH VEIN OCCLUSION [J].
GREER, DV ;
CONSTABLE, IJ ;
COOPER, RL .
AUSTRALIAN JOURNAL OF OPHTHALMOLOGY, 1980, 8 (03) :207-209
[10]  
Hoeh AE, 2007, OPHTHALMOLOGE, V104, P290, DOI 10.1007/s00347-007-1514-0